Investigators used cerebellar organoids differentiated from hiPSCs combined with CRISPR/Cas9 gene editing to investigate the earliest molecular and cellular consequences of Patched 1 (PTCH1) mutations on human cerebellar development.
[Disease Models & Mechanisms]